🇺🇸 FDA
Patent

US 10398769

Influenza nucleic acid molecules and vaccines made therefrom

granted A61KA61K2039/53A61K39/12

Quick answer

US patent 10398769 (Influenza nucleic acid molecules and vaccines made therefrom) held by Inovio Pharmaceuticals, Inc. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/53, A61K39/12, A61K39/145